HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 277, Issue 14, 12208-12214, April 5, 2002

This Article Abstract Full Text (PDF) All Versions of this Article: 277/14/12208    most recent M111874200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Garnier, C. Articles by Peyrot, V. Search for Related Content PubMed PubMed Citation Articles by Garnier, C. Articles by Peyrot, V. Social Bookmarking                      What's this?

Binding of ATP to Heat Shock Protein 90

EVIDENCE FOR AN ATP-BINDING SITE IN THE C-TERMINAL DOMAIN^*

Cyrille Garnier^§, Daniel Lafitte^¶, Philipp O. Tsvetkov^¶, Pascale Barbier^¶, Jocelyne Leclerc-Devin, Jean-Marc Millot^**, Claudette Briand^¶, Alexander A. Makarov, Maria G. Catelli, and Vincent Peyrot^¶

From the  CNRS-UPR 1524, ICGM, 24 rue du Faubourg Saint Jacques, Paris 75014, France, ^¶ UMR-CNRS 6032, Faculté de Pharmacie, 27 Blvd. Jean Moulin, 13385 Marseille Cedex 5, France,  Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov str. 32, Moscow 119991, Russia, ^** Laboratoire de Spectroscopie Biomoléculaire, Faculté de Pharmacie, 51 rue Cognacq Jay, Reims Cedex 51096, France

Received for publication, December 13, 2001, and in revised form, January 17, 2002

	ABSTRACT

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

The presence of a nucleotide binding site on hsp90 was very controversial until x-ray structure of the hsp90 N-terminal domain, showing a nonconventional nucleotide binding site, appeared. A recent study suggested that the hsp90 C-terminal domain also binds ATP (Marcu, M. G., Chadli, A., Bouhouche, I., Catelli, M. G., and Neckers, L. M. (2000) J. Biol. Chem. 275, 37181-37186). In this paper, the interactions of ATP with native hsp90 and its recombinant N-terminal (positions 1-221) and C-terminal (positions 446-728) domains were studied by isothermal titration calorimetry, scanning differential calorimetry, and fluorescence spectroscopy. Results clearly demonstrate that hsp90 possesses a second ATP-binding site located on the C-terminal part of the protein. The association constant between this domain of hsp90 and ATP-Mg and a comparison with the binding constant on the full-length protein are reported for the first time. Secondary structure prediction revealed motifs compatible with a Rossmann fold in the C-terminal part of hsp90. It is proposed that this potential Rossmann fold may constitute the C-terminal ATP-binding site. This work also suggests allosteric interaction between N- and C-terminal domains of hsp90.

	INTRODUCTION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Prokaryotic and eukaryotic cells exposed to heat and other cellular stresses synthesize several classes of highly conserved stress proteins (1). These protein families act as molecular chaperones by preventing the aggregation of nonnative polypeptides and providing the guideline for their correct folding. Heat shock protein 90 (hsp90)¹ is one of the most abundant proteins in eukaryotic cells under heat shock and stress conditions and is also constitutively expressed, representing 1-2% of the total cellular protein in the majority of eukaryotic cells growing in unstressed conditions (2). hsp90 acts in complex with a set of partner proteins to assist target protein folding (for a review, see Ref. 3).

Sequence alignments and proteolytic digests have shown that hsp90 is composed of well conserved N-terminal and C-terminal domains linked by a charged hinge region variable in length (4). X-ray crystallographic studies of the N-terminal domain (residues 1-220) of yeast and human hsp90 allowed the identification of the ATP-Mg/ADP-Mg binding site, which can be blocked by high affinity inhibitors such as the antibiotic geldanamycin (GA) (5, 6) or radicicol (7). This site is responsible for the ATPase activity of the chaperone (8). Via the ATP-binding site, the N-terminal domain seems to regulate hsp90 conformation (9) and contains a chaperone site involved in the binding of target proteins (8). In contrast to the N terminus, the three-dimensional structure of the C-terminal domain of hsp90 is still unknown. This domain contains a second chaperone site, which has different polypeptide specificity from the N-terminal one (10). Moreover, the C-terminal region seems to be involved in both dimerization (11-13) and oligomerization (14) of hsp90. The mechanism of dimer formation has been proposed to take place through the duplicate anti-parallel interaction of fragments 542-615 and 629-731 (12). ATP binding and hydrolysis produce conformational changes that involve the entire hsp90 molecule, and the C-terminal region of hsp90 seems important for trapping the nucleotide during the ATPase cycle (15, 16). Moreover, a second ATP-binding site located in hsp90 C terminus was suggested through the use of ATP-Sepharose affinity chromatography (17); however, the association constant and stoichiometry of the complex with ATP were not determined. Thus, characterization of the C-terminal domain interaction with nucleotides is crucial to understand the hsp90 function. Therefore, we expressed C- and N-terminal domains separately and applied differential scanning calorimetry (DSC), isothermal titration calorimetry (ITC), and fluorescence spectroscopy to directly prove that hsp90 contains a second ATP-binding site located in the C-terminal part of the protein and to determine the association constant for C-hsp90·ATP-Mg complex. Then we compared this value with the binding constant obtained for the full-length protein and hypothesized the localization of the second ATP-binding site.

	EXPERIMENTAL PROCEDURES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

hsp90 Purification and Expression of N- and C-terminal Domains-- The 90-kDa heat shock protein was purified from porcine brain according to the method of Ref. 18, modified by Garnier et al. (19, 20). N-hsp90 (positions 1-221) and C-hsp90 domains were obtained by PCR amplification using a chicken hsp90 cDNA-bearing plasmid pSKB3 90 (13) and inserted into pET 15b and pET 28a expression vectors (Novagen) in frame with the N-terminal His tag, respectively. The constructs were verified by automated sequencing and transformed into Epicurean Coli Bl21-Gold (DE3) pLys Competent cells (Stratagene). Bacterial cells bearing the pET 15b and pET 28a constructs were grown overnight at 37 °C. The expression of fusion proteins was induced with 1 mM isopropyl-1-thio--D-galactopyranoside for 3 h at 37 °C for N-hsp90 and overnight at 20 °C for C-hsp90. Subsequently, cells were lysed by French press in extraction buffer A1 (100 mM phosphate, 100 mM NaCl, pH 7.4); the lysate was clarified by ultracentrifugation at 30,000 × g for 30 min. The recombinant proteins were purified by Hi-trap affinity column (Amersham Biosciences) and eluted using a 0-250 mM imidazole gradient in A1 buffer. Fractions containing recombinant protein were pooled and concentrated using Amicon cells (Millipore Corp.). Concentrated proteins were desalted on a PD10 column (Amersham Biosciences).

All purified proteins were stored at 80 °C in 10 mM Tris-HCl, pH 7.5. Protein concentration was determined by UV absorbance with extinction coefficients at 280 nm of 124,000, 51,100, and 16,350 M¹ cm¹ for hsp90, C-terminal domain, and N-terminal domain, respectively. Extinction coefficients were calculated by the procedure of Gill and Von Hippel on the basis of the amino acid composition (19). All experiments were carried out in 10 mM Tris-HCl buffer, pH 7.5.

Circular Dichroism-- CD spectra of 12 µM hsp90 were acquired with a Jasco J-720 spectropolarimeter using a 0.01-cm cell at 25 °C. The instrument was calibrated between 180 and 350 nm with ammonium camphorsulfonate-d₁₀ (Katayama Chemical, Jasco) as a standard. The results were expressed as molar ellipticity, [] (degrees cm² dmol¹), considering an average amino acid residue mass of 111 Da. CD spectra were analyzed by four different methods currently available in the Dicroprot program (version 2.4 by G. Deleage; available on the World Wide Web at www.ibcp.fr/).

Fourier Transform Infrared Spectroscopy (FTIR)-- FTIR spectra of 80 µl of hsp90 (100 µM) were obtained with a resolution of 4 cm¹ using a MB100 FTIR spectrometer equipped with a deuterated triglycine sulfate detector (21). Secondary structures content was calculated from Amide I and II bands using partial least-squares analysis as described in Ref. 22. This factor analysis requires a calibration set of proteins with known x-ray structures (21). The first five loading vectors were used, and three types of secondary structures were characterized: -helix, -sheet, and undefined structures.

hsp90 Cross-linking Experiments-- Chemical cross-linking of hsp90 was performed using N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) (Sigma) as cross-linking reagent. The optimal EDC concentration determined by titration was equal to 1.5 mM. hsp90 (6 µM) was incubated 10 min at room temperature in the presence or absence of various concentrations of Mg²⁺, and the influence of ligands (3.5 × 10⁴ M GA and 5 mM ATP-Mg complex) on hsp90 cross-linking was tested. For cross-linking, 32 mM EDC stock solution was added (5% of hsp90 sample volume), and samples were incubated for 30 min at room temperature. To stop the cross-linking process, samples were diluted 3-fold with buffer (a 20-fold excess of amine containing buffer is enough to quench the reaction). Then samples were submitted to 4-15% gradient native PAGE using the PhastSystem apparatus (Amersham Biosciences). Gels were stained with Coomassie Brilliant Blue.

Differential Scanning Calorimetry-- Measurements of hsp90 and its N- and C-terminal domain heat denaturation and influence of ATP-Mg or ATP alone on this process were carried out on a MicroCal VP-DSC instrument in 0.51 ml cells at a heating rate of 1 K/min. Protein concentration varied from 2.3 to 6 µM. The heating curves were corrected for the instrumental base line obtained by heating the solvent used for protein solution. The excess molar heat capacity of the protein (C) and denaturation temperature were determined as described elsewhere (23), using molecular masses of 169,900 (20), 27,800, and 83,000 Da for hsp90 dimer, N-hsp90 monomer, and C-hsp90 dimer, respectively. The functions of excess heat capacity were analyzed using the MicroCal Origin software. The accuracy of denaturation temperatures was within 0.2 °C.

Isothermal Titration Calorimetry-- Binding of ATP to hsp90 and C-hsp90 was carried out at 25 °C in three different conditions: in the presence of 5 mM free Mg²⁺, in the absence of added magnesium, and in the absence of added magnesium but in the presence of 1 mM EDTA, using a MicroCal MCS titration calorimeter. Enthalpy of binding (H), and equilibrium constant (K_a) were obtained using the following procedure. 5-10-µl aliquots of ligands (2-4 × 10³ M) were injected from a 250-µl microsyringe into the 1.34-ml calorimeter cell containing protein solution (1.0-2.5 × 10⁵ M) to achieve a complete binding isotherm. The heat of dilution was measured by injecting the ligand into the buffer solution or by additional injections of ligand after saturation; the value obtained was subtracted from the heat of reaction to obtain effective heat of binding. Titration curves were fitted using the MicroCal Origin software, assuming a single class of site.

Fluorescence-- Relative fluorescence was measured on a Perkin-Elmer LS 50 with slit widths of 5 and 10 nm. Fluorescence data were obtained using 0.2 cm (excitation direction) × 1 cm (emission direction) cells at 25 ± 0.5 °C. The excitation was done at 295 nm to specifically excite the hsp90 tryptophan residues and to minimize the ATP absorption. The measurements were carried out in the presence of 2 mM magnesium. Equilibrium difference fluorescence measurements were conducted at constant hsp90 concentration and increasing ATP concentration. The difference in fluorescence (F) at 340 nm between hsp90 fluorescence and hsp90-ATP complex fluorescence (F = F_hsp90  F_complex) was plotted versus ATP concentrations. The inner filter was corrected, and the curve was fitted to the saturation curve equation by nonlinear least-squares regression analysis (24).

Sequence Analysis and Predictive Methods-- The - and -hsp90 sequences available in SWISS-PROT data base were used for the multiple-sequence alignments. Location of sequence variation within aligned family members was determined by the PHD program as previously described (25). Predictions of secondary structure and solvent accessibility for pig and human hsp90 (HS9A_PIG, HS9A_HUMAN) and hsp90 (HS9B_HUMAN) were obtained from the PHD server (26). The PHDsec method (27-30) uses the information contained in multiple-sequence alignments as input to a neural network trained with a nonredundant protein structure data base. It has been reported to have the best predictive accuracy when only sequence information is available (31). Predictions of the secondary structure through the amino acid sequences of HS9A_PIG, HS9A_HUMAN, and HS9B_HUMAN were also performed with the nnpredict program (32, 33).

Sedimentation Velocity-- Sedimentation velocity experiments were performed at 55,000 rpm in a Beckman Optima XL-A analytical ultracentrifuge equipped with an AnTi 55 rotor and 12-mm aluminum double-sector centerpieces. Data were acquired in continuous mode at 280 or 230 nm depending on protein concentrations. The data were analyzed using the SVEDBERG (34) and dcdt (35) computer programs.

Sedimentation Equilibrium-- Sedimentation equilibrium runs were performed at 20 °C at three loading concentrations and at three speeds in a six-channel centerpiece of charcoal-filled Epon. The protein gradients were detected at 280 nm. High speed sedimentation was conducted afterward for base-line correction. Data analysis was performed by global analysis of several data sets obtained at different loading concentrations at one speed using the program MULTEQ3B (36).

	RESULTS

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

Characterization of hsp90 and Its Recombinant Domains-- Two HSP90 fragments were expressed in Escherichia coli and purified. The amino-terminal domain (N-hsp90) was designed to end at residue 221, which includes the ATP-binding site (5). The carboxyl-terminal domain (C-hsp90) started at position 446 to the end of the sequence. It included the recently suggested second ATP-binding site (17). The two proteins showed electrophoretic homogeneity in SDS-PAGE, with molecular masses of about 30 and 40 kDa, respectively. N-hsp90 eluted from size exclusion chromatography-HPLC with an apparent molecular mass of 28 kDa and a Stokes radius of 19.2 Å. Sedimentation equilibrium experiments at three loading concentrations and three speeds confirmed that N-hsp90 was monomeric. Global analysis of three concentrations at one speed using a single ideal species model converged to the value of 28.1 kDa, highly compatible with the theoretical molecular mass of the monomer (27.8 kDa). Velocity sedimentation experiments allowed the determination of a sedimentation coefficient at infinite dilution at 20 °C in water, s of 2.42 ± 0.02 S. Analysis of C-hsp90 by native PAGE and size exclusion chromatography demonstrated that the C-hsp90 sample contained 30-40% dimers with an apparent molecular mass of 100 kDa and a Stokes radius of 41.7 Å and 60-70% of oligomers with apparent molecular masses ranging from 170 to 400 kDa and Stokes radii ranging from 41.7 to 60 Å. Analytical ultracentrifugation experiments confirmed heterogeneity of C-hsp90 quaternary structures and indicated a polydisperse sample.

The far-UV CD spectrum of the full-length hsp90 was analyzed by four different methods (see "Experimental Procedures"), and results are shown in Table I. The average values were as follows: 38% -helix, 15% -sheet, and 47% other structures. The component assignment of the deconvoluted spectra of the amide I and II infrared absorption bands of hsp90 by FTIR showed that hsp90 contained 44% -helix, 17% -sheet and 39% undefined structure. The PHD algorithm and the nnpredict program were used to create a picture of -human hsp90 secondary structure content (Fig. 1, line PHDsec and line nnp, respectively). Prediction methods did not show significant differences between hsp90 and hsp90 (data not shown). In addition, the secondary structures content of the N-terminal subdomain (residues 12-223) obtained by predictive methods (PHDsec and nnpredict) and the secondary structure content deduced from x-ray three-dimensional structure (6) (Fig. 2), were highly similar with the exception of the first strand (residues 16-21) and the sixth -helix (residues 129-135); all remaining structural elements predicted are present in the crystallographic structure. This indicates that the PHD method gave a good estimation of secondary structure, and it may be used for the entire protein (Fig. 1).

View larger version (46K): [in this window] [in a new window]   Fig. 1.   Secondary structure and solvent accessibility predictions of pig hsp90. The residue number and the sequence of amino acid residues are indicated. The secondary structure prediction by the PHDsec method is graphically displayed with helical symbols, arrows, and ribbons for -helices, extended -sheet strands, and undefined, respectively. The predictions with an expected accuracy under and over 81.2% are in light yellow and red, respectively. Secondary structures predicted by the nnpredict method (nnp) (32, 33) are shown on the secondary structure scheme (PHDsec) (27-30); residues enclosed in an -helix and a -strand are indicated by  and , respectively. The three-state solvent accessibility prediction by the PHDacc method is shown below. e, exposed; b, buried; blank, intermediate solvent accessibility.

View larger version (19K): [in this window] [in a new window]   Fig. 2.   Comparison between the N-terminal domain secondary structure of HSP90 obtained through crystal three-dimensional structure (upper line) and the predicted secondary structure obtained by the PHDsec (27-30) and nnpredict (32,33) methods. -Helices and extended -sheet strands are represented by cylinders and arrows, respectively. For the PHDsec method, only predictions corresponding to an expected accuracy over 81.2% are represented.

Influence of ATP on Mg²⁺-dependent Oligomerization Process of hsp90-- As demonstrated earlier, hsp90 dimer undergoes a Mg²⁺-dependent oligomerization process implicating the C-terminal domain (19). GA did not influence the cross-linkage profile observed in the presence or absence of Mg²⁺ (Fig. 3, lines A4 and B4). Contrary to GA, ATP inhibited the Mg²⁺-dependent oligomerization process (Fig. 3, line C2). Considering a binding constant of 2.2 × 10⁴ M¹ (37), in our experimental conditions about 90% of Mg²⁺ was bound to ATP, and only 0.5 mM Mg²⁺ was free (Fig. 3, gel C). To further raise the free Mg²⁺, the total Mg²⁺ concentration was increased to 10 mM, maintaining the same ATP concentration (5 mM) (Fig. 3, gel D). In these conditions and despite the presence of more than 5 mM free Mg²⁺, no hsp90 oligomerization process was observed (Fig. 3, lane D2). Thus, ATP inhibited hsp90 oligomerization induced by Mg²⁺ ions. Since GA does not influence the Mg²⁺-dependent oligomerization and ATP is known to compete with GA for the N-terminal ATP-binding site (5, 9, 38, 39), we tried to reverse the inhibitory effect of ATP by a large GA concentration (3.5 × 10⁴ M). Considering the association constants of 7.6 × 10³ and 2 × 10⁶ M¹ for ATP (5) and geldanamycin (39), respectively, the N-terminal domain was saturated at 93% with GA in our experimental conditions. Fig. 3 (lanes C3 and D3) demonstrates that GA did not reverse the inhibitory effect of ATP. Hence, ATP inhibited hsp90 oligomerization by binding to a site different from the N-terminal one, possibly located in the C terminus of the protein.

View larger version (26K): [in this window] [in a new window]   Fig. 3.   Effect of GA and ATP on the hsp90 Mg2+-dependent oligomerization process. The presence and the absence of reagents is indicated by + and , respectively. Concentrations of Mg2+ and ligands are indicated on the left. In all experiments, the last component added was EDC. Samples were analyzed on 4-15% gradient native PAGE with the PhastSystem apparatus. D and O indicate migration of dimeric and oligomeric species, respectively.

Influence of ATP on Thermal Stability of hsp90, N-hsp90, and C-hsp90-- To obtain additional proof that ATP binds to the C-terminal part of hsp90, heat denaturation of the three proteins (hsp90, N-hsp90, and C-hsp90) and effects of ATP-Mg and ATP alone were studied by DSC. In a previous study, we showed that the melting curve of hsp90 consists of two transitions; on the basis of the specific GA binding and stabilization, the lower temperature peak corresponded to the melting of the N-terminal domain, while the higher temperature one comprised denaturation of the C-terminal domain (19). As already reported (5), the N-terminal domain of hsp90 does not contain a divalent cation-binding site but binds ATP-Mg. Fig. 4A and Table II show that ATP-Mg increased by 2.6 °C the denaturation temperature of N-hsp90 and increased by 2.0 °C the temperature of the N-terminal domain unfolding in the entire protein. Unfortunately, strong aggregation, accompanying thermal denaturation of C-hsp90 in the presence of magnesium, did not allow us to register a reliable heat absorption peak, and the addition of ATP shifted the thermogram to higher temperatures without decreasing the aggregation (Fig. 4B). The same was true for the second peak of the hsp90 melting curve (Table II). The aggregation was also observed after completion of heat denaturation of N-hsp90 in the presence of ATP-Mg (Fig. 4A).

View larger version (15K): [in this window] [in a new window]   Fig. 4.   Raw DSC data for N-hsp90 (A) and C-hsp90 (B) at pH 7.5 with (dashed line) and without (solid line) 5 mM ATP in the presence of 5 mM magnesium.

To avoid aggregation, the influence of ATP on thermal denaturation of hsp90 and its recombinant domains was studied in the absence of added Mg²⁺ (but possibly with residual Mg²⁺ on the protein), thus allowing us to register the whole melting process of hsp90, N-hsp90, and C-hsp90. The hsp90 melting curve consisted of two transitions (Fig. 5A, solid line). Contrary to GA that essentially stabilized the first transition peak (19), the experiment performed in presence of ATP showed a shift of the two transition peaks (+1.9 °C and +2.9 °C, respectively), indicating that the nucleotide stabilized both the amino- and carboxyl-terminal domain of hsp90 (Fig. 5A, dashed line). Melting curves of recombinant proteins consisted of a single transition (Fig. 5B, solid lines). As for native hsp90, ATP protected N-hsp90, increasing its denaturation temperature by 1.7 °C (Fig. 5A, 2). In the presence of ATP, the C-hsp90 denaturation temperature increased by 7.5 °C. Along with increased thermal stability of C-hsp90, the ATP addition resulted in the disappearance of protein aggregation occurring immediately after completion of its melting. According to size exclusion chromatography-HPLC data, increasing temperature until 61 °C (near the beginning of the C-hsp90 heat absorption peak) led to the complete aggregation of C-hsp90 oligomers without modification of dimer quantity (data not shown). For this reason, (i) the melting peak for C-hsp90 (Fig. 5B, 2) represented melting of only dimers, and (ii) the low value of denaturation enthalpy was due to the fact that the calculation was based on total C-hsp90 concentration, without any consideration of the more complex C-hsp90 quaternary structure. Fig. 5 and Table II show that free hsp90 domains and those in the intact protein exhibited different melting sensitivity. Noteworthy, the N-hsp90 stability decreased by 5.7 °C as compared with that of N-terminal domain in the whole hsp90, whereas the C-hsp90 denaturation temperature was 7.5 °C higher than that of the corresponding portion in the entire protein. In the presence of ATP, this difference reached 12 °C for C-hsp90. These results clearly point toward mutual interdomain interaction in the hsp90 molecule. Most importantly, these data clearly demonstrate that whole hsp90 and its isolated domains are all significantly stabilized by ATP addition and that ATP interacts with the C-terminal domain of hsp90. Actually, there are many examples showing that the ligand specific binding to a protein domain results in the increase of thermal stability of this domain and, consequently, an increased thermal stability indicates ligand binding (41).

View larger version (18K): [in this window] [in a new window]   Fig. 5.   Temperature dependence of the excess heat capacity of hsp90 (A), N-hsp90 (B, 1) and C-hsp90 (B, 2) with (dashed line) and without (solid line) 5 mM ATP.

hsp90 and C-hsp90 Binding to ATP-Mg Studied by ITC and Fluorescence Spectroscopy-- ATP binding to hsp90 was studied by ITC in the presence (Fig. 6A) or absence of additional Mg²⁺ and in the presence of 1 mM EDTA. In the presence of EDTA, no heat exchange was monitored (data not shown). Without additional Mg²⁺ (without EDTA) a weak heat exchange due to the binding of ATP to hsp90 was observed; it was, however, too small to be correctly analyzed (data not shown). In the presence of 5 mM Mg²⁺, the heat exchange due to the binding of ATP-Mg to hsp90 could be monitored, giving a correct enthalpy titration curve, which was fitted assuming a single class of sites. The thermodynamic parameters are reported in Table III, showing that the stoichiometric equilibrium constant was in the millimolar range (K_a = 5 × 10³ M¹), and the binding was enthalpy-driven with an unfavorable entropy.

View larger version (19K): [in this window] [in a new window]   Fig. 6.   ITC data curves of ATP-Mg/hsp90 (A) and ATP-Mg/C-hsp90 interaction (B). The molar ratio is the ratio between [ATP-Mg] and the [hsp90] or [C-hsp90].

The C-hsp90/ATP-Mg binding curves obtained by ITC were also fitted (Fig. 6) assuming a single class of site. According to the thermodynamic parameters reported in Table III, the binding was enthalpy-driven. The variation of enthalpy (79 kJ mol¹) and the affinity constant (K_a = 5.5 × 10⁴ M¹) were stronger than those obtained for the entire protein (K_a = 5 × 10³ M¹) (Table III). Noteworthy, the peaks corresponding to the heat signal associated with each injection were wider than for the protein alone, showing that a slow mechanism, probably a structural change, also took place during the binding of ATP-Mg (Fig. 6B).

C-hsp90 possesses one tryptophan residue. During complex formation with ATP, the fluorescence emission spectrum can either shift in the wavelength of maximum fluorescence emission or shift in fluorescence intensity. These shifts can therefore be used to evaluate the association constant. In the presence of Mg²⁺, when ATP-Mg was added, the maximum of fluorescence emission spectrum at 340 nm of C-hsp90 decreased, confirming the formation of a C-hsp90-ATP-Mg complex. The interaction did not induce any wavelength shift (data not shown). Fluorescence changes were recorded as successive ATP aliquots were added to a solution of 5 µM C-hsp90. The intensity changes at 340 nm (mean of 10 values) were plotted versus ATP concentrations (Fig. 7). The data were corrected from the inner filter effect and fitted by a nonlinear least-squares procedure, yielding the apparent stoichiometric equilibrium constant for ATP-Mg binding to C-hsp90 of 2.5 × 10⁴ M¹, which was in the same range as that determined by ITC.

View larger version (12K): [in this window] [in a new window]   Fig. 7.   Fluorimetric titration of C-hsp90 (5 µM) at 25 °C with various ATP concentrations in 10 mM Tris-HCl, 2 mM magnesium, pH 7.5. Symbols represent the experimental points (collected at 340 nm), and the solid line is the fitting curve obtained.

	DISCUSSION

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

GA and ATP possess a common hsp90 binding site located in the N-terminal domain (5, 9, 39). Although both ligands protect hsp90 from heat-induced oligomerization (19, 42), they display, as shown here, different effects on the divalent cation-dependent hsp90 oligomerization process. Whereas ATP inhibited this process, GA had no effect, and despite saturating GA concentration, no reversion of ATP inhibitory effect was observed. The absence of the reversion effect in the presence of GA indicated that ATP and GA did not compete for divalent cation-dependent hsp90 oligomerization process. Thus, ATP inhibition should occur through a nucleotide binding site different from the well known N-terminal one, possibly located in the hsp90 C-terminal domain, where a novobiocin/ATP-binding site has been recently suggested (17). Therefore, this second ATP site was characterized using expression of N- and C-terminal fragments, leading to the first comparative ATP-Mg binding study in solution between the entire protein and the C-terminal fragment. DSC, ITC, and fluorescence analysis unambiguously showed that ATP-Mg also bound to the C-hsp90, suggesting that four nucleotide binding sites exist on hsp90 dimer. The enthalpy resulting from the binding of ATP-Mg on the entire protein or on the C-terminal fragment of hsp90 was strongly favorable, showing, in agreement with x-ray data (5), that hydrogen bonds and van der Waals contacts are created and water molecules are trapped at the binding interface. The entropy of binding was negative due in part to the trapping of water molecules at the binding interface and to a possible rigidification of the complex. The enthalpy and the entropy of ATP-Mg binding on the entire protein were more than 3 times higher in absolute terms than those of ATP-Mg binding on the C-terminal fragment (see Table III). To sum up, our data suggest that the nucleotide on the N-terminal part of the molecule has a strong negative impact on the binding of the nucleotide on the C-terminal part. Indeed, the affinity of the C terminus alone for ATP-Mg was stronger than the affinity of the entire protein, showing that the addition of separated domains of the protein was not equal to that of the entire protein, as also demonstrated by DSC. Thus, important interdomain interactions occur in hsp90 dimer, as already suggested by others (43, 44).

hsp90 is one of the most conserved proteins known. Despite only 60% amino acid identity, three-dimensional structures of N-hsp90 from yeast and human are almost identical (5, 6, 38). Vertebrates hsp90 and hsp90 are related by 85% amino acid identity in the same species, and all hsp90 or hsp90 show more than 95% identity between them (96% for chicken and human). Thus, results obtained for native pig hsp90, composed of 83% -isoform and 17% -isoform (20), recombinant -chicken domains, and - or -human (predictions) are highly comparable and could be applied to - or -hsp90 from other eukaryotic species. This was confirmed by investigation of hsp90 secondary structure by spectral (CD and FTIR) and by predictive methods (PHD and nnpredict). Using hydrophobic cluster analysis, we proposed that hsp90 contains a potential Rossmann fold between amino acids 490 and 630, suggesting that the protein could have an NADH reductase activity (45). However, using ITC, we did not detect the binding of NADH to hsp90. Using deletion/mutation analysis, a binding site for novobiocin/ATP was localized in a region overlapping the carboxyl-terminal dimerization domain of the chaperone (mutant 4, amino acids 538-728), where the two ligands compete (17). Thus, it seems reasonable to propose that the C-terminal ATP-binding site could be localized between amino acids 538 and 630, because the secondary structure analysis showed that this region is highly structured in a succession of -helices and -sheets (_555-581-_{585-591 598-601}-_607-618) compatible with a Rossmann fold motif known to bind ATP. Since -phosphate-linked ATP-Sepharose bound the mutant 4, amino acids 538-630 seems sufficient for purine base binding as confirmed by competition with GTP and not with CTP (17). The peptide 657-677 seems to be crucial for nucleotide and novobiocin binding, because the corresponding deletion mutant was unable to bind ATP Sepharose, and an excess of the same peptide (residues 657-677) inhibited the binding of mutant 4 to ATP and novobiocin-Sepharose (17). As the mechanism of dimer formation occurs through the duplicate antiparallel interaction of fragments 542-615 and 629-731 (12), the 657-677 peptide from one monomer could participate in the formation of the ATP-binding site of the other monomer, and vice versa. Moreover, deletion of this peptide induced hsp90 monomerization (13). The C-terminal ATP-binding site thus overlaps with the dimerization domain, explaining why ATP binding, dimerization, and magnesium-dependent oligomerization processes are closely linked.

To sum up, we characterized the second ATP-binding site located on the C terminus of hsp90. The binding may occur on a Rossmann fold region previously suggested (45). The comparison of binding constants for ATP-Mg between this domain of hsp90 and the full-length protein and the nucleotide obtained by ITC and the DSC results demonstrate interdomain interactions. Whether this second site contributes to hsp90 ATP activity and how it communicates with the N-terminal one remain to be determined.

	ACKNOWLEDGEMENTS

We gratefully acknowledge Prof. Gilbert Deleage for help in CD spectra analysis and Virginie Aiello for help in protein purification.

	FOOTNOTES

^* This work was supported by CNRS, "Association pour la Recherche contre le Cancer," and "ligue contre le cancer (indre et loire et île de France)" and International Association for the Promotion of Cooperation with Scientists from the New Independent States of the Former Soviet Union/Russian Foundation for Basic Research Grant 97-105.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

^§ Supported by "Societé de Secours des Amis des Sciences."

To whom correspondence should be addressed. Tel.: 33-491835505; Fax: 33-491782024; E-mail: vincent.peyrot@pharmacie.univ-mrs.fr.

Published, JBC Papers in Press, January 22, 2002, DOI 10.1074/jbc.M111874200

	ABBREVIATIONS

The abbreviations used are: hsp, heat shock protein; N-hsp90, segment 1-221 of hsp90; C-hsp90, segment 446-728 of hsp90; GA, geldanamycin; FTIR, Fourier transform infrared; ITC, isothermal titration calorimetry; DSC, differential scanning calorimetry; EDC, N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride; HPLC, high pressure liquid chromatography.

	REFERENCES

TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. K. Allan, D. Mok, B. K. Ward, and T. Ratajczak Modulation of Chaperone Function and Cochaperone Interaction by Novobiocin in the C-terminal Domain of Hsp90: EVIDENCE THAT COUMARIN ANTIBIOTICS DISRUPT Hsp90 DIMERIZATION J. Biol. Chem., March 17, 2006; 281(11): 7161 - 7171. [Abstract] [Full Text] [PDF]

				P. J. M. Murphy, Y. Morishima, J. J. Kovacs, T.-P. Yao, and W. B. Pratt Regulation of the Dynamics of hsp90 Action on the Glucocorticoid Receptor by Acetylation/Deacetylation of the Chaperone J. Biol. Chem., October 7, 2005; 280(40): 33792 - 33799. [Abstract] [Full Text] [PDF]

				A. Martinez-Ruiz, L. Villanueva, C. G. de Orduna, D. Lopez-Ferrer, M. A. Higueras, C. Tarin, I. Rodriguez-Crespo, J. Vazquez, and S. Lamas S-nitrosylation of Hsp90 promotes the inhibition of its ATPase and endothelial nitric oxide synthase regulatory activities PNAS, June 14, 2005; 102(24): 8525 - 8530. [Abstract] [Full Text] [PDF]

				J. E. Whittier, Y. Xiong, M. C. Rechsteiner, and T. C. Squier Hsp90 Enhances Degradation of Oxidized Calmodulin by the 20 S Proteasome J. Biol. Chem., October 29, 2004; 279(44): 46135 - 46142. [Abstract] [Full Text] [PDF]

				M. P. Goetz, D. O. Toft, M. M. Ames, and C. Erlichman The Hsp90 chaperone complex as a novel target for cancer therapy Ann. Onc., August 1, 2003; 14(8): 1169 - 1176. [Abstract] [Full Text] [PDF]